Cost-Effectiveness Analysis of Exenatide Twice Daily (BID) Versus Insulin Glargine Once Daily (QD) as Add-On Therapy in Chinese Patients With Type 2 Diabetes Mellitus Inadequately Controlled by Oral Therapies

Value in Health- United Kingdom

doi 10.1016/j.jval.2015.09.2105

Full Text

Abstract

Available in

Date

Authors

Publisher

Elsevier BV

Related search

Cost-Effectiveness of Exenatide Twice Daily (Bid) Added to Basal Insulin Compared to a Bolus Insulin Add-On in Turkey

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Efficacy and Safety of Three-Times-Daily Versus Twice-Daily Biphasic Insulin Aspart 30 in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Combined With Oral Antidiabetic Drugs

Diabetes Research and Clinical Practice
Internal MedicineEndocrinologyMetabolismMedicineDiabetes
2019English

Assessing Insulin Effectiveness at the End of the Day: Once-Daily Versus Twice-Daily Insulin Glargine Injection

Journal of Diabetes Mellitus
2012English

Cost-Effectiveness Analysis of Liraglutide Versus Sitagliptin or Exenatide in Patients With Inadequately Controlled Type 2 Diabetes on Oral Antidiabetic Drugs in Greece

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Patients With Type 2 Diabetes Inadequately Controlled on Premixed Insulin: Effect of Initiating Insulin Glargine Plus Oral Antidiabetic Agents on Glycaemic Control in Daily Practice*

International Journal of Clinical Practice
Medicine
2007English

Exenatide Twice Daily Versus Insulin Glargine for the Treatment of Type 2 Diabetes in Poland — Subgroup Data From a Randomised Multinational Trial GWAA

Endokrynologia Polska
EndocrinologyMetabolismDiabetes
2013English

The Comparative Study With Lixisenatide /Glargine Combination Therapy Versus Twice-Daily Premixed Insulin Therapy/DPP-4 Inhibitor on Glycemic Variability, and Feeding Behavior in Obese Patients With Type 2 Diabetes Mellitus

Health and Primary Care
2018English

The Cost-Effectiveness of Alogliptin Versus Sulfonylurea as Add-On Therapy to Metformin in Patients With Uncontrolled Type 2 Diabetes Mellitus

Diabetes Therapy
Internal MedicineEndocrinologyMetabolismDiabetes
2016English

Pdb68 - Cost-Effectiveness Analysis of Exenatide Versus GLP-1 Receptor Agonists in Patients With Type 2 Diabetes Mellitus

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy